Life Sciences MVP: Sullivan's Krishna Veeraraghavan
Krishna Veeraraghavan's experience at the helm of multiple record-breaking deals benefited Teva Pharmaceuticals earlier this year when the pharmaceutical giant abruptly switched from a $40 billion bid for Mylan to a...To view the full article, register now.
Already a subscriber? Click here to view full article